3,098
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis

, , , , , , , , & ORCID Icon show all
Pages 973-982 | Received 23 Sep 2022, Accepted 24 Oct 2022, Published online: 03 Nov 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.